Skip to content

Study of Ethanol lock therapy for Central Venous Catheter-Related Bloodstream Infection

Study of Ethanol lock therapy for Central Venous Catheter-Related Bloodstream Infection - Study of Ethanol lock therapy for CRBSI

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000013677
Enrollment
10
Registered
2014-04-10
Start date
2014-04-10
Completion date
Unknown
Last updated
2025-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

catheter related blood stream infection

Interventions

Sponsors

Department of Pediatrics, Hamamatsu University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria:

Exclusion criteria

Exclusion criteria: Patients have allergy for ethanol. Patients have severe liver disfunction, total bilirubin 3 mg / dL or more, ascites difficult management, severe bleeding tendency.

Design outcomes

Primary

MeasureTime frame
Improvement of CRBSI

Secondary

MeasureTime frame
Safety of ethanol lock

Countries

Japan

Contacts

Public ContactKimiyoshi Sakaguchi

Hamamatsu University School of Medicine Department of Pediatrics

k-saka@hama-med.ac.jp053-435-2312

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Feb 20, 2026